This application combines biochemical, morphological and autoradiographic techniques to study slow axonal transport in normal and experimental conditions as well as the mechanism of action of compounds which specifically affect organization and transport of axonal cytoskeletal components. Three projects are proposed. Project 1: The distribution of proteins transported with the component b of the slow transport (SCb) in the transverse plane of the axon will be studied by quantitative autoradiography in animals treated wih b,b'-iminodipropionitrile (IDPN), a toxic compound that produces a segregation of axonal neurofilaments (NF) from microtubules (MT).
The aim of this project is to examine the role played by NF and/or MT in the translocation of SCb. Project 2: Slow axonal transport is investigated in the R2 giant neuron of Aplysia californica under normal conditions and following treatment with IDPN and other toxic compounds affecting NF transport.
The aim of this project is to take advantage of a enirely dissectable system to investigate a) basic aspects of slow axonal transport such as changes of cytoskeletal proteins during axonal transport along the most proximal regions of the axon; b) pathogenetic aspects of the NF axonopathies such as formation of NF containing enlargement. These studies cannot be performed in more complex axonal systems. Project 3: deals with the mechanism(s) of action of chemical compounds specifically affecting slow axonal transport and cytoskeletal organization. Possible interactions of neurotoxic compounds with NF and other cytoskeletal proteins and the molecular mechanism involved in the increased rate of NF transport, a characteristic effect of some of these compounds, will be investigated. The understanding the molecular basis of the experimental giant neuropathies may help clarify the pathogenesis of similar human diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS014509-08A1
Application #
3395595
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1985-07-01
Project End
1988-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
8
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Gambetti, P; Parchi, P; Petersen, R B et al. (1995) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 5:43-51
Tabaton, M (1994) Research advances in the biology of Alzheimer's disease. Clin Geriatr Med 10:249-55
Monari, L; Chen, S G; Brown, P et al. (1994) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A 91:2839-42
Tabaton, M; Nunzi, M G; Xue, R et al. (1994) Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun 200:1598-603
Bacci, B; Cochran, E; Nunzi, M G et al. (1994) Amyloid beta precursor protein and ubiquitin epitopes in human and experimental dystrophic axons. Ultrastructural localization. Am J Pathol 144:702-10
Cammarata, S; Caponnetto, C; Tabaton, M (1993) Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia? Neurosci Lett 156:96-8
Petersen, R B; Tabaton, M; Berg, L et al. (1992) Analysis of the prion protein gene in thalamic dementia. Neurology 42:1859-63
Cammarata, S; Tabaton, M (1992) Ubiquitin-reactive axons have a widespread distribution and are unrelated to prion protein plaques in Creutzfeldt-Jakob disease. J Neurol Sci 110:32-6
Goldfarb, L G; Petersen, R B; Tabaton, M et al. (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806-8
LeBlanc, A C; Kovacs, D M; Chen, H Y et al. (1992) Role of amyloid precursor protein (APP): study with antisense transfection of human neuroblastoma cells. J Neurosci Res 31:635-45

Showing the most recent 10 out of 37 publications